414 related articles for article (PubMed ID: 18212657)
1. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia.
Mueller EW; Croce MA; Boucher BA; Hanes SD; Wood GC; Swanson JM; Chennault SK; Fabian TC
J Trauma; 2007 Dec; 63(6):1329-37; discussion 1337. PubMed ID: 18212657
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
Magnotti LJ; Schroeppel TJ; Clement LP; Swanson JM; Bee TK; Maish GO; Minard G; Zarzaur BL; Fischer PE; Fabian TC; Croce MA
J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
[TBL] [Abstract][Full Text] [Related]
3. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
[TBL] [Abstract][Full Text] [Related]
4. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
[TBL] [Abstract][Full Text] [Related]
6. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
7. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
Magnotti LJ; Croce MA; Zarzaur BL; Swanson JM; Wood GC; Weinberg JA; Fabian TC
J Am Coll Surg; 2011 Apr; 212(4):476-84; discussion 484-6. PubMed ID: 21463773
[TBL] [Abstract][Full Text] [Related]
8. Surveillance culture utility and safety using low-volume blind bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia.
Boots RJ; Phillips GE; George N; Faoagali JL
Respirology; 2008 Jan; 13(1):87-96. PubMed ID: 18197916
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumonia.
Raghavendran K; Wang J; Belber C; Misra SR; Brunton K; Berbary E; Burke MS; Haas CE
J Trauma; 2007 Jun; 62(6):1377-82; discussion 1382-3. PubMed ID: 17563652
[TBL] [Abstract][Full Text] [Related]
11. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].
Fekih Hassen M; Ayed S; Ben Sik Ali H; Gharbi R; Marghli S; Elatrous S
Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
[TBL] [Abstract][Full Text] [Related]
13. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
14. Utility of preliminary bronchoalveolar lavage results in suspected ventilator-associated pneumonia.
Swanson JM; Wood GC; Croce MA; Mueller EW; Boucher BA; Fabian TC
J Trauma; 2008 Dec; 65(6):1271-7. PubMed ID: 19077612
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of preliminary bacterial colony counts from bronchoalveolar lavage in critically ill trauma patients.
Mueller EW; Wood GC; Kelley MS; Boucher BA; Fabian TC; Croce MA
Am Surg; 2003 Sep; 69(9):749-55; discusiion 755-6. PubMed ID: 14509321
[TBL] [Abstract][Full Text] [Related]
16. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage.
Miller PR; Meredith JW; Chang MC
J Trauma; 2003 Aug; 55(2):263-7; discussion 267-8. PubMed ID: 12913635
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for relapse of ventilator-associated pneumonia in trauma patients.
Rangel EL; Butler KL; Johannigman JA; Tsuei BJ; Solomkin JS
J Trauma; 2009 Jul; 67(1):91-5; discussion 95-6. PubMed ID: 19590315
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of diagnostic techniques for ventilator-associated pneumonia.
Canadian Critical Care Trials Group
N Engl J Med; 2006 Dec; 355(25):2619-30. PubMed ID: 17182987
[TBL] [Abstract][Full Text] [Related]
20. Comparison of quantitative bronchoscopic lavage cultures (B-BAL) with blind NG tube lavage (N-BAL) cultures in the diagnosis of ventilator associated pneumonia (VAP).
Hussain SM; Abubaker J; Ali M; Noor A; Khurshid M; Dildar B; Khan SG
J Coll Physicians Surg Pak; 2009 Apr; 19(4):245-8. PubMed ID: 19356341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
